Blocking of CXCR4 with a neutralizing antibody decrease prostate cancer cell invasivity, inhibits homing of prostate cancer cells to the bone and also attenuate growth of prostate cancer cells in bone [104]. The gene discussed is CXCR4; the disease is prostate carcinoma.